Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL5735496

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
Dopamine D2 Receptor Agonism: Dopamine D2 receptor agonism was measured using a calcium mobilization assay protocol developed by HD Biosciences (China). Briefly, HEK293/G15 cells expressing human D2 receptor were plated at a density of 15000 cells/well in clear-bottomed, Matrigel-coated 384-well plates and grown for 24 hrs at 37° C. in the presence of 5% CO2. The cells were incubated with calcium-sensitive fluorescent dye, Fluo8, for 60-90 minutes at 37° C. in the dark. Test compounds were prepared at 3-fold concentrated solution in 1×HBSS buffer with Ca2+ and Mg2+. Calcium Flux signal was immediately recorded after compounds were added from compound plate to cell plate at FLIPR (Molecular Devices). The fluorescence data were normalized to yield responses for no stimulation (buffer) and full stimulation (1 μM of dopamine) of 0% and 100% stimulation, respectively. Test compound potency (EC50) was estimated by nonlinear regression using the sigmoidal dose-response (variable slope) using Xlfit 4 (IDBS, Guildford, Surrey, UK, model 205).y=(A+((B−A)/(1+((C/x){circumflex over ( )}D))))where y is the normalized ratio measurement for a given concentration of test compound, x is the concentration of test compound, A is the estimated efficacy at infinite compound dilution, and B is the maximal efficacy. C is the EC50 value and D is the Hill slope coefficient.EC50 estimates were obtained from independent experiment and the logarithmic average was calculated.
21
Total Activities
6
Compounds Tested
3
Activity Types
0
Assay Parameters

Assay Information

Assay Type Binding
Organism Homo sapiens
Confidence 9 — Direct single protein target
Curated By Autocuration

Target

D(2) dopamine receptor (CHEMBL217)
Type SINGLE PROTEIN
Organism Homo sapiens

Publication

Catecholamine prodrugs for use in the treatment of Parkinson's disease
(2020)

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
EC50 7 7.02 8.89
kon 7 - -
k_off 7 - -

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL405519 3 8.89
CHEMBL5910957 3 7.34
CHEMBL6015867 3 5.96
CHEMBL5743564 6 5.89
CHEMBL5879441 3 -
CHEMBL6051083 3 -

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL405519 EC50 = 1.3 nM 8.89
CHEMBL5910957 EC50 = 46.0 nM 7.34
CHEMBL6015867 EC50 = 1100.0 nM 5.96
CHEMBL5743564 EC50 = 1300.0 nM 5.89
CHEMBL405519 kon = - -
CHEMBL405519 k_off = - s-1 -
CHEMBL5879441 EC50 > 1000.0 nM -
CHEMBL5879441 kon = - -
CHEMBL5879441 k_off = - s-1 -
CHEMBL5910957 kon = - -
CHEMBL5910957 k_off = - s-1 -
CHEMBL6015867 k_off = - s-1 -
CHEMBL5743564 kon = - -
CHEMBL5743564 k_off = - s-1 -
CHEMBL6051083 EC50 > 30000.0 nM -
CHEMBL6051083 kon = - -
CHEMBL6051083 k_off = - s-1 -
CHEMBL5743564 EC50 > 30000.0 nM -
CHEMBL5743564 kon = - -
CHEMBL5743564 k_off = - s-1 -
CHEMBL6015867 kon = - -